(Q35702126)

9 August 2017

1 reference

title

Neuroblastoma: evolving therapies for a disease with many faces (English)

1 reference

9 August 2017

1 reference

Robert E Goldsby

1

1 reference

9 August 2017

Katherine K Matthay

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

107-122

1 reference

Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group

9 August 2017

cites work

1 reference

12 December 2020

Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms

1 reference

12 December 2020

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

12 December 2020

A population-based study of the usefulness of screening for neuroblastoma

1 reference

12 December 2020

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

1 reference

12 December 2020

131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.

1 reference

12 December 2020

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3

1 reference

12 December 2020

Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors

1 reference

12 December 2020

The fetal alcohol syndrome and neuroblastoma

1 reference

12 December 2020

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis

1 reference

12 December 2020

Constitutional 1p36 deletion in a child with neuroblastoma.

1 reference

12 December 2020

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

1 reference

12 December 2020

Screening for neuroblastoma: a 9-year birth cohort-based study in Niigata, Japan

1 reference

12 December 2020

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

1 reference

12 December 2020

Neuroblastoma: biology and therapy

1 reference

12 December 2020

trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study

1 reference

12 December 2020

Correlating telomerase activity levels with human neuroblastoma outcomes

1 reference

12 December 2020

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study

1 reference

12 December 2020

Breast-feeding and neuroblastoma, USA and Canada

1 reference

12 December 2020

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

12 December 2020

Retinoid therapy of childhood cancer.

1 reference

12 December 2020

Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.

1 reference

12 December 2020

Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child

1 reference

12 December 2020

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

1 reference

12 December 2020

Gravid health status, medication use, and risk of neuroblastoma.

1 reference

12 December 2020

The Transformation of a Malignant Paravertebral Sympathicoblastoma into a Benign Ganglioneuroma

1 reference

12 December 2020

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

12 December 2020

Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines

1 reference

12 December 2020

Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines

1 reference

12 December 2020

Survival of children with neuroblastoma treated with combination chemotherapy

1 reference

12 December 2020

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children

1 reference

12 December 2020

Biology and genetics of human neuroblastomas.

1 reference

12 December 2020

NEUROCYTOMA OR NEUROBLASTOMA, A KIND OF TUMOR NOT GENERALLY RECOGNIZED.

1 reference

12 December 2020

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

1 reference

12 December 2020

Increased urinary HVA levels in neuroblastoma screens related to diet, not tumor

1 reference

12 December 2020

PET hydroxyephedrine imaging of neuroblastoma

1 reference

12 December 2020

The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric Oncology

1 reference

12 December 2020

Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma)

1 reference

12 December 2020

The International Neuroblastoma Pathology Classification (the Shimada system).

1 reference

12 December 2020

The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma

1 reference

12 December 2020

Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children's Hospital.

1 reference

12 December 2020

Familial neuroblastoma. Case reports, literature review, and etiologic considerations

1 reference

12 December 2020

Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection

1 reference

12 December 2020

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

1 reference

12 December 2020

A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy

1 reference

12 December 2020

Successful management of stage 4S neuroblastoma and severe hepatomegaly using absorbable mesh in an infant

1 reference

12 December 2020

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma

1 reference

12 December 2020

Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease

1 reference

12 December 2020

Expression and function of TRK-B and BDNF in human neuroblastomas

1 reference

12 December 2020

Abdominal Masses in Children: Neuroblastoma, Wilms tumor, and Other Considerations

1 reference

12 December 2020

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

12 December 2020

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 reference

12 December 2020

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1 reference

12 December 2020

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma

1 reference

12 December 2020

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

1 reference

12 December 2020

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies

1 reference

12 December 2020

17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group

1 reference

12 December 2020

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis

1 reference

12 December 2020

Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines

1 reference

12 December 2020

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

12 December 2020

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma

1 reference

12 December 2020

Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro

1 reference

12 December 2020

Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma

1 reference

12 December 2020

Decrease in childhood neuroblastoma death in Japan

1 reference

12 December 2020

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's

1 reference

12 December 2020

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

1 reference

12 December 2020

Activated expression of the N-myc gene in human neuroblastomas and related tumors

1 reference

12 December 2020

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

1 reference

12 December 2020

Screening of infants and mortality due to neuroblastoma

1 reference

12 December 2020

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

1 reference

12 December 2020

Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan

1 reference

12 December 2020

Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.

1 reference

12 December 2020

Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity

1 reference

12 December 2020

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

12 December 2020

Applications of nuclear medicine in pediatric oncology

1 reference

12 December 2020

Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature

1 reference

12 December 2020

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

1 reference

12 December 2020

Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma

1 reference

12 December 2020

Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads

1 reference

12 December 2020

Neuroblastoma Screening at One Year of Age

1 reference

12 December 2020

Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma.

1 reference

12 December 2020

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

12 December 2020

Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study

1 reference

12 December 2020

Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome

1 reference

12 December 2020

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study

1 reference

12 December 2020

Significance of chromosome 1p loss of heterozygosity in neuroblastoma

1 reference

12 December 2020

The role of surgery in the management of stage IV neuroblastoma: a single institution study

1 reference

12 December 2020

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

12 December 2020

Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma

1 reference

12 December 2020

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

12 December 2020

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors

1 reference

12 December 2020

Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.

1 reference

12 December 2020

Neuroblastoma and parental occupation

1 reference

12 December 2020

Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma

1 reference

12 December 2020

Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification

1 reference

12 December 2020

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

12 December 2020

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma

1 reference

12 December 2020

Targeted expression of MYCN causes neuroblastoma in transgenic mice

1 reference

12 December 2020

Vasoactive intestinal peptide secreting tumours in children: a case report with literature review

1 reference

12 December 2020

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

1 reference

12 December 2020

Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome

1 reference

12 December 2020

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

12 December 2020

Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma

1 reference

12 December 2020

Familial predisposition to neuroblastoma does not map to chromosome band 1p36

1 reference

12 December 2020

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione

1 reference

12 December 2020

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party

1 reference

12 December 2020

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy

1 reference

12 December 2020

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

12 December 2020

Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study

1 reference

12 December 2020

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

12 December 2020

Electron beam intraoperative radiation therapy for pediatric neoplasms

1 reference

12 December 2020

Local control with multimodality therapy for stage 4 neuroblastoma

1 reference

12 December 2020

Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group

1 reference

12 December 2020

Expression of TrkC in favorable human neuroblastomas

1 reference

12 December 2020

MYCN protein expression as a predictor of neuroblastoma prognosis.

1 reference

12 December 2020

Spontaneous regression of localized neuroblastoma detected by mass screening

1 reference

12 December 2020

Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study

1 reference

12 December 2020

Medical and drug risk factors associated with neuroblastoma: a case-control study.

1 reference

12 December 2020

Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study

1 reference

12 December 2020

Effects of retinoic acid on the in vivo growth of human neuroblastoma cells

1 reference

12 December 2020

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group

1 reference

12 December 2020

Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma

1 reference

12 December 2020

ENSG 1-randomised study of high-dose melphalan in neuroblastoma

1 reference

12 December 2020

Unique management of stage 4S neuroblastoma complicated by massive hepatomegaly: case report and review of the literature

1 reference

12 December 2020

Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results

1 reference

12 December 2020

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

1 reference

12 December 2020

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

1 reference

12 December 2020

Neuroblastoma: a single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors

1 reference

12 December 2020

Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group

1 reference

12 December 2020

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

12 December 2020

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

12 December 2020

Perinatal factors and risk of neuroblastoma

1 reference

12 December 2020

Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study

1 reference

12 December 2020

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

1 reference

12 December 2020

The treatment of neuroblastoma with [131I]MIBG at diagnosis

1 reference

12 December 2020

Telomerase activity as a prognostic factor in neuroblastomas

1 reference

12 December 2020

CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies

1 reference

12 December 2020

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

1 reference

12 December 2020

10.2165/00148581-200406020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1053220193

0 references

Fatcat ID

release_chz3eeii7nckpg6ktyzdqaysxu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/chz3eeii7nckpg6ktyzdqaysxu

24 November 2022

mapped directly with Wikidata item

1 reference